Skip to content

Observational study on risk factors contributing to disease progression among patients with cardiogenic shock.

Observational study on risk factors contributing to disease progression among patients with cardiogenic shock.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096967
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Shock

Interventions

case series:NA

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age Range: Above 18 years old; 2. Meeting the diagnostic criteria for cardiogenic shock: Presence of hypotensive manifestations and at least one sign of inadequate organ perfusion; 3. Hypotensive Manifestations: In the context of adequate blood volume, systolic blood pressure 2mmol/L; 5. Patients or their authorized representatives agree to participate in this study, sign a written informed consent form, and are willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with clearly identified other causes of shock at admission (such as hemorrhage, trauma, medications, etc.) and assessed by the investigator to have non-cardiogenic causes as the primary reason for shock; 2. Patients undergoing continuous cardiopulmonary resuscitation for more than 60 minutes without the establishment of ECMO or other mechanical assistive support; 3. Patients with cardiogenic shock who have entered Stage E according to the SCAI staging system; 4. Individuals who have participated in other new drug clinical trials within the last 3 months; 5. Patients with psychiatric disorders, alcoholism, or abuse and dependency on psychoactive substances; 6. Patients with missing medical record information or physiological and chemical indicators; 7. Patients deemed unsuitable for participation in this study by the investigator; 8. Pregnant women, women planning to become pregnant, and lactating women.

Design outcomes

Primary

MeasureTime frame
all-cause mortality;cardiovascular death;Compound endpoint of adverse cardiovascular events (PCI driven by myocardial ischemia or hospitalization, readmission of recurrent myocardial infarction, stroke, heart failure);

Secondary

MeasureTime frame
End stage renal disease requires hemodialysis;hospital stay;Hospitalization expenses;Quality of life score;

Countries

China

Contacts

Public ContactXue Ling

Guangdong Provincial People's Hospital

xueling@gdph.org.cn+86 137 1112 8345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026